Portable Medical Diagnosis Instrument

Many diseases are accompanied by characteristic odors. Their recognition can provide diagnostic clues, guide the laboratory evaluation, and affect the choice of immediate therapy. The study of the chemical composition of human breath using gas chromatography mass spectrometry (GC/MS) has shown a correlation between the volatile compounds and the occurrence of certain illnesses. The presence of those specific compounds can provide an indication of physiological malfunction and support the diagnosis of diseases. This condition requires an analytical tool with very high sensitivity for its measurement. A number of volatile compounds, so called biomarkers, are found in breath samples, normally at low parts per billion (ppb) levels. For example, the acetone in the exhaled breath from human with other biomarkers can indicate Type I diabetes. Usually, the concentration of the volatile compounds in human breath is very low and the background relative humidity is high, almost 100%. NASAs invention utilizes an array of chemical sensors combined with humidity, temperature, and pressure for real-time breath measurement to correlate the chemical information in the breath with the state and functioning of different human organs. This tool provides a non-invasive method for fast and accurate diagnosis at the medical point of care or at home. The sensor chip includes multisensors for a comprehensive measurement of chemical composition, temperature, humidity, and pressure/flow rate. The sensor data collected from this chip can be wired or wirelessly transmitted to a computer terminal at the doctors desk or hospital monitoring center. The sensor chip can be connected directly or via Universal serial bus (USB) to a cell phone for data transmission over a long distance and receive an instruction from a doctors office for an immediate therapy.

The handheld digital microscope features a 3D-printed chassis to house its hardware, firmware, and rechargeable Li-ion battery with built-in power management. It incorporates an internal stainless-steel cage system to enclose and provide mechanical rigidity for the optics and imaging sensor. To reduce the microscope’s size, yet retain high spatial resolution, engineers devised an optical light path that uniquely folds back on itself using high reflectivity mirrors, thus significantly reducing internal volume. Imaging control and acquisition is performed using a secure web-based graphical user interface accessible via any wireless enabled device. The microscope serves as its own wireless access point thus obviating the need for a pre-existing network. This web interface enables multiple simultaneous connections and facilitates data sharing with clinicians, scientists, or other personnel as needed. Acquired images can be stored locally on the microscope server or on a removable SD card. Data can be securely downloaded to other devices using a range of industry standard protocols. Although the handheld digital microscope was originally developed for in-flight medical diagnosis in microgravity applications, prototypes were thoroughly ground-tested in a variety of environments to verify the accurate resolve of microbial samples for identification and compo-sitional analysis for terrestrial field use. Owing to its portability, other applications demanding rapid results may include research, education, veterinarian, military, contagion disaster response, telemedicine, and point-of-care medicine.

The NASA developed Micro-Organ Device (MOD) platform technology is a small, lightweight, and reproducible in vitro drug screening model that can inexpensively biomimic different mammalian tissues for a multitude of applications. The technology is automated and imposes minimal demands for resources (power, analytes, and fluids). The MOD technology uses titanium tetra(isopropoxide) to bond a microscale support to a substrate and uses biopattering and 3D tissue bioprinting on a microfluidic microchip to eliminate variations in local seeding density while minimizing selection pressure. With the MOD, pharmaceutical companies can test more candidates and concentrate on those with more promise therefore, reducing R&D overall cost. This innovation overcomes major disadvantages of conventional in vitro and in vivo experimentation for purposes of investigating effects of medicines, toxins, and possibly other foreign substances. For example, the MOD platform technology could host life-like miniature assemblies of human cells and the effects observed in tests performed could potentially be extrapolated more readily to humans than could effects observed in conventional in vitro cell cultures, making it possible to reduce or eliminate experimentation on animals. The automated NASA developed technology with minimal footprint and power requirements, micro-volumes of fluids and waste, high throughput and parallel analyses on the same chip, will advance the research and development for new drugs and materials.

PUMA represents a major breakthrough in portable metabolic analysis. It is a rugged, compact device that measures human metabolic function at rest, during exercise, in clinical settings, and in extreme environments. Metabolic measurements are a clinically proven method of monitoring cardiovascular health and fitness levels. The PUMA headgear features NASA-developed sensors that evaluate six key metabolic functions. Specifically, PUMA measures oxygen and carbon dioxide partial pressure in addition to temperature, pressure, airflow, and heart rate. By placing sensors close to the mouth, PUMA can record up to 30 (or more) detailed measurements for each breath. From these measurements, PUMA computes metabolically relevant quantities of oxygen uptake, carbon dioxide output, minute ventilation, respiration rate, and heart rate. With additional software, the device computes heart rhythm, tidal volume, and alveolar and dead-space volumes. A small embedded computer controls and acquires data from all sensors at 10 hertz (Hz), performs calculations, and transmits data wirelessly to a remote computer. The PUMA sensors are low power, stable, and capable of operating in a range of environments, including very high and low pressures as well as high- and low-oxygen environments. This portable device provides real-time measurements that are just as accurate as the large stationary metabolic carts used in hospitals. PUMA can be used not only in clinical settings but also in the extreme/remote environments of space, aviation, underwater, and deep underground. Because it detects real-time dangerous drops in oxygen, it can ensure astronaut cardiovascular health; predict the onset of hypoxia in pilots, divers, and first responders; and advance chronic pulmonary disease monitoring and athletic training.

To stain a specimen slide, one or more liquid reagents are injected via the dispenser into the slide staining device via a syringe port. The volume of a given reagent is determined by adjustable settings on the dispenser, so that when connected to the staining device, initiates a thin film over the slide. The dispensing device uses only a fraction of the reagents typically used in non-sealed environments. Medical grade polyvinyl alcohol sponges have been incorporated into the dispenser to provide additional fluid containment and retention during the staining procedure. Furthermore, the dispenser can recall excess reagent, minimizing reagent use until refill. The slide staining device is composed of an upper and lower section held together and aligned by use of Nd magnets. With the device open, a specimen slide is positioned upon a silicone gasket that sits within a recess in the lower section. When the device is closed, the silicone gasket in the upper section applies a seal to the slide forming a cavity that allows the slide to be exposed to reagents injected from the connected dispenser creating a stain through the use of capillary forces. Although originally designed for use in microgravity, the slide staining system also works in gravity environments. Numerous applications may exist for this technology, particularly in hematology and cellular biology. Other applications could be considered for academic research, veterinary field use, military, disaster stricken and remote environments or where fine control of fluid delivery, removal, and management is desired. The slide staining system is at technology readiness level (TRL) 8 (actual system completed and "flight qualified" through test and demonstration), and are now available to license. Please note that NASA does not manufacture products itself for commercial sale.